Cleared Traditional

K150700 - ACP 1 Anterior Cervical Plating System (FDA 510(k) Clearance)

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K150700 · Stryker Corporation · Orthopedic device

Download Printable Device Report (PDF)

Optimized for regulatory review, auditing and printing

Jul 2015

Decision

119d

Days

Class 2

Risk

K150700 is an FDA 510(k) clearance for the ACP 1 Anterior Cervical Plating System. Classified as Appliance, Fixation, Spinal Intervertebral Body (product code KWQ), Class II - Special Controls.

Submitted by Stryker Corporation (Allendale, US). The FDA issued a Cleared decision on July 15, 2015 after a review of 119 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3060 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Stryker Corporation devices

Submission Details

510(k) Number	K150700 FDA.gov
FDA Decision	Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received	March 18, 2015
Decision Date	July 15, 2015
Days to Decision	119 days
Submission Type	Traditional
Review Panel	Orthopedic (OR)
Summary	Summary PDF
Third-party Review	No - reviewed directly by FDA

Regulatory Context

Review time vs. panel average

3d faster than avg

Panel avg: 122d · This submission: 119d

Pathway characteristics

Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code	KWQ Appliance, Fixation, Spinal Intervertebral Body
Device Class	Class 2 - Special Controls
CFR Regulation	21 CFR 888.3060

What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.